Amit M Oza Selected Research

ferrous fumarate drug combination ethinyl estradiol norethindrone acetate (Zoran)

1/2019

FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amit M Oza Research Topics

Disease

89	Neoplasms (Cancer) 01/2022 - 01/2003
76	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
22	Carcinoma (Carcinomatosis) 01/2022 - 04/2010
19	Disease Progression 01/2022 - 01/2013
18	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 09/2005
18	Ovarian Epithelial Carcinoma 01/2021 - 02/2007
11	Fatigue 01/2021 - 06/2008
11	Neutropenia 01/2021 - 01/2010
9	Hypertension (High Blood Pressure) 12/2021 - 01/2010
9	Diarrhea 01/2020 - 07/2008
9	Anemia 01/2020 - 04/2010
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 07/2010
7	Nausea 01/2020 - 06/2008
6	Asthenia 01/2021 - 01/2017
5	Fallopian Tube Neoplasms 12/2021 - 07/2008
5	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2010
4	Proteinuria 12/2021 - 07/2014
4	Thrombocytopenia (Thrombopenia) 01/2021 - 12/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2002
4	Vomiting 01/2020 - 08/2017
4	Adenocarcinoma 12/2019 - 07/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 11/2014
3	Hypoxia (Hypoxemia) 01/2016 - 06/2012
3	Hemorrhage 07/2014 - 01/2008
2	Microsatellite Instability 01/2022 - 12/2014
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 12/2014
2	Intestinal Obstruction (Obstruction, Intestinal) 01/2021 - 01/2017
2	Exanthema (Rash) 01/2021 - 04/2010
2	Hand-Foot Syndrome 01/2020 - 04/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 03/2005
2	Neoplasm Metastasis (Metastasis) 10/2017 - 01/2003
2	Abdominal Pain (Pain, Abdominal) 01/2017 - 07/2014
2	Ascites 10/2016 - 07/2014
2	Fistula 08/2015 - 01/2008
2	Carcinosarcoma 08/2014 - 04/2010
2	Mucositis 11/2013 - 10/2013
2	Lymphoma (Lymphomas) 03/2011 - 05/2009
1	Heart Diseases (Heart Disease) 01/2022

Drug/Important Bio-Agent (IBA)

46	PlatinumIBA 01/2022 - 08/2007
31	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2013
19	rucaparibIBA 01/2022 - 01/2017
15	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2002
13	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 01/2016
13	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2014
12	olaparibIBA 01/2021 - 10/2013
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2012
11	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2008
9	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2011
7	Pharmaceutical PreparationsIBA 01/2020 - 04/2010
7	niraparibIBA 01/2020 - 12/2016
5	adavosertibIBA 01/2022 - 12/2016
5	Gemcitabine FDA Link 01/2021 - 01/2006
5	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 01/2006
4	Poly Adenosine Diphosphate RiboseIBA 01/2022 - 04/2017
4	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2009
4	Phosphotransferases (Kinase)IBA 12/2016 - 06/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 01/2008
4	TOR Serine-Threonine KinasesIBA 11/2015 - 10/2012
4	temsirolimus FDA Link 02/2014 - 08/2011
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2017
3	Angiogenesis InhibitorsIBA 01/2021 - 12/2009
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2020 - 10/2012
3	veliparibIBA 01/2020 - 04/2015
3	trebananibIBA 10/2016 - 02/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2016 - 07/2008
3	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 04/2010
3	ridaforolimusIBA 11/2015 - 02/2014
3	MTOR InhibitorsIBA 11/2015 - 10/2012
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2015 - 10/2013
3	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 05/2015 - 10/2013
3	epothilone B (EPO906)IBA 04/2011 - 12/2005
2	Monoclonal AntibodiesIBA 12/2021 - 06/2008
2	VaccinesIBA 08/2021 - 03/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 08/2017
2	TabletsIBA 01/2021 - 01/2017
2	Alanine Transaminase (SGPT)IBA 01/2021 - 08/2017
2	avelumabIBA 01/2021 - 01/2021
2	binimetinibIBA 11/2020 - 12/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 12/2019
2	Hormones (Hormone)IBA 01/2020 - 09/2011
2	ENMD 2076IBA 12/2018 - 01/2013
2	AntigensIBA 10/2017 - 07/2009
2	ParaffinIBA 10/2016 - 05/2010
2	Angiopoietin-1IBA 10/2016 - 02/2012
2	Peptides (Polypeptides)IBA 08/2015 - 02/2012
2	Sunitinib (Sutent)FDA Link 11/2014 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 01/2008
2	Drug CombinationsIBA 10/2013 - 06/2012
2	Biological ProductsIBA 10/2012 - 02/2007
2	Vorinostat FDA Link 03/2011 - 05/2009
2	Decitabine FDA Link 03/2011 - 05/2009
2	Antineoplastic Agents (Antineoplastics)IBA 10/2006 - 07/2002

Therapy/Procedure

66	Drug Therapy (Chemotherapy) 01/2022 - 07/2002
51	Therapeutics 01/2022 - 06/2003
4	Radiotherapy 08/2021 - 09/2005
3	Immunotherapy 08/2021 - 08/2015
3	Precision Medicine 01/2019 - 06/2016
2	Neoadjuvant Therapy 01/2021 - 01/2020
2	Adjuvant Chemotherapy 01/2019 - 01/2019